MC/CAR-Z2 [derivative of MC/CAR (ATCC CRL-8083)] (ATCC
MC/CAR-Z2 [derivative of MC/CAR (ATCC CRL-8083)] (ATCC
规格:
货期:
编号:TS211527
品牌:Testobio
| 产品名称： | MC/CAR-Z2 derivative of MC/CAR (ATCC CRL-8083) (ATCC® CRL-8147™) |
|---|---|
| 商品货号： | TS211527 |
| Organism： | Homo sapiens, human |
| Cell Type： | B lymphocyte |
| Product Format： | frozen |
| Morphology： | lymphoblast |
| Culture Properties： | suspension |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Disease： | plasmacytoma; myeloma |
| Age： | 81 years |
| Gender： | male |
| Ethnicity： | Caucasian |
| Applications： | Resistant to 8-azaguanine. |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Clinical Data： | male Caucasian 81 years |
| Comments： | Resistant to 8-azaguanine. Will die in HAT medium within 15 to 20 days. |
| Complete Growth Medium： | RPMI 1640 medium with 0.02 mg/ml 8-azaguanine, 80%; fetal bovine serum, 20%
|
| Subculturing： | Medium Renewal: 2 to 3 times per week Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 5 X 10 exp5 cells/ml and maintain between 4 X 10 exp5 and 5 X 10 exp6 cells/ml. |
| Population Doubling Time： | 20 to 24 hrs |
首页 >
产品中心
>
微生物培养
>
菌株
>
null
>
MC/CAR-Z2 [derivative of MC/CAR (ATCC CRL-8083)] (ATCC
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | MC/CAR-Z2 derivative of MC/CAR (ATCC CRL-8083) (ATCC® CRL-8147™) |
|---|---|
| 商品货号： | TS211527 |
| Organism： | Homo sapiens, human |
| Cell Type： | B lymphocyte |
| Product Format： | frozen |
| Morphology： | lymphoblast |
| Culture Properties： | suspension |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Disease： | plasmacytoma; myeloma |
| Age： | 81 years |
| Gender： | male |
| Ethnicity： | Caucasian |
| Applications： | Resistant to 8-azaguanine. |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Clinical Data： | male Caucasian 81 years |
| Comments： | Resistant to 8-azaguanine. Will die in HAT medium within 15 to 20 days. |
| Complete Growth Medium： | RPMI 1640 medium with 0.02 mg/ml 8-azaguanine, 80%; fetal bovine serum, 20%
|
| Subculturing： | Medium Renewal: 2 to 3 times per week Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 5 X 10 exp5 cells/ml and maintain between 4 X 10 exp5 and 5 X 10 exp6 cells/ml. |
| Population Doubling Time： | 20 to 24 hrs |
